+29.1%
MRNA vs STT
+194.3%
-165.1%
-86.6%
Performance
Returns, benchmark comparison, and relative performance.
Performance by timeframe
Returns for 3y.
| Period | Portfolio | STT | Excess | Alpha |
|---|---|---|---|---|
| 1D | +0.7% | -0.3% | +1.1% | +0.8% |
| 7D | -8.2% | -1.4% | -6.9% | -7.8% |
| 30D | +125.6% | +2.2% | +123.4% | +120.9% |
| 3M | +197.1% | +18.8% | +178.2% | +163.6% |
| 6M | +148.5% | +57.9% | +90.6% | +82.5% |
| YTD | +363.3% | +51.0% | +312.3% | +247.7% |
| 1Y | +462.0% | +77.1% | +384.8% | +279.2% |
| All | +29.1% | +194.3% | -165.1% | -33.4% |
Cumulative growth
Daily Returns
Daily percentage return beside STT.
Daily Out/Under-Performance
Portfolio return minus STT return. Positive bars indicate outperformance.
Daily Alpha
Portfolio daily return minus β × STT return. Early observations use the first valid beta; later observations use the trailing beta estimated for each date.
Cumulative Out/Under-Performance
Relative wealth over 3y: compounded portfolio wealth divided by compounded STT wealth, less one. Both series rebase at the selected span's start.
Cumulative Alpha
Compounded beta-adjusted residual returns apply the first valid beta to early observations, then the trailing beta ending on each date.
Updating return analytics…
3y analysis · Full analysis span regression · 6 months rolling